LifeMD Inc（LFMD）财务数据LFMDLifeMD Inc

LifeMD Inc (LFMD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Telehealth, accounting for 100.0% of total sales, equivalent to $50.16M. Other significant revenue streams include Telehealth Subscription Revenue and Telehealth Product Revenue. Understanding this composition is critical for investors evaluating how LFMD navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, LifeMD Inc maintains a gross margin of 88.82%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -15.08%, while the net margin is -14.98%. These profitability ratios, combined with a Return on Equity (ROE) of -763.47%, provide a clear picture of how effectively LFMD converts its operational activities into shareholder value.

In the context of the broader market, LFMD competes directly with industry leaders such as NAKA and XGN. With a market capitalization of $157.13M, it holds a significant position in the sector. When comparing efficiency, LFMD's gross margin of 88.82% stands against NAKA's 49.70% and XGN's 61.27%. Such benchmarking helps identify whether LifeMD Inc is trading at a premium or discount relative to its financial performance.

LifeMD reported Q2 2026 revenue of $47.3 million, which was below expectations, and has a forward P/E of 12.85, indicating potential undervaluation but also uncertainty in earnings recovery.